DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Norketamine is an investigational drug.
There have been 8 clinical trials for Norketamine. The most recent clinical trial was a Phase 1 trial, which was initiated on February 1st 2016.
The most common disease conditions in clinical trials are Pain, Postoperative, Chronic Pain, and Depressive Disorder, Major. The leading clinical trial sponsors are University of Texas Southwestern Medical Center, Columbia University, and Arkansas Children's Hospital Research Institute.
There are thirteen US patents protecting this investigational drug and fifty-nine international patents.
Recent Clinical Trials for Norketamine
|The Role of HNKs in the Antidepressant Effect of Ketamine||Columbia University||Phase 1|
|Acute Pain Management in Patients on Opioid Replacement Therapy||University of California, San Francisco||Phase 1|
|Inhaled Nebulised S(+)-Ketamine for Postoperative Analgesia||Tampere University Hospital||Phase 4|
Top disease conditions for Norketamine
Top clinical trial sponsors for Norketamine
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Norketamine||Start Trial||Ketamine derivatives||Auckland Uniservices Limited (Auckland, NZ)||Start Trial|
|Norketamine||Start Trial||Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods||Amorsa Therapeutics, Inc. (Littleton, MA)||Start Trial|
|Norketamine||Start Trial||Assay for methoxetamine||Randox Laboratories Ltd. (GB)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|